Bicycle Therapeutics (BCYC) EBT (2018 - 2026)
Bicycle Therapeutics (BCYC) reported EBT of -$60.7 million for Q1 2026, up 1.92% on a YoY basis from -$59.5 million in Q1 2025, and down 137.51% quarter-over-quarter from -$25.5 million in Q4 2025.
Bicycle Therapeutics (BCYC) EBT (2018 - 2026) Analysis & Trends
Bicycle Therapeutics has reported EBT for 9 years, with the latest figure at -$60.7 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 1.92% year-over-year to -$60.7 million; the trailing twelve-month figure through Mar 2026 stood at -$224.3 million (down 670.31% YoY), and the FY2025 full-year result was -$225.5 million, down 3977.81% from the prior year.
- EBT for Q1 2026 stood at -$60.7 million, down from -$25.5 million in the prior quarter.
- The five-year high for EBT was $126.7 million in Q4 2024, with the low at -$79.2 million in Q2 2025.
- Historically, EBT has averaged -$34.1 million across 5 years, with a median of -$39.7 million in 2024.
- Annual changes were most pronounced in 2024 — EBT soared 341.05% — and 2025, when it slumped 129.78%.
- Bicycle Therapeutics' EBT stood at -$32.4 million in 2022, then slumped by 62.04% to -$52.6 million in 2023, then soared by 341.05% to $126.7 million in 2024, then slumped by 120.16% to -$25.5 million in 2025, then plunged by 137.51% to -$60.7 million in 2026.
- The last three EBT figures came in at -$60.7 million (Q1 2026), -$25.5 million (Q4 2025), and -$58.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | -60.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.65 Mn |
| Dec 31, 2025 | -25.54 Mn |
| Sep 30, 2025 | -58.90 Mn |
| Jun 30, 2025 | -79.18 Mn |
| Mar 31, 2025 | -61.84 Mn |
| Dec 31, 2024 | 126.67 Mn |
| Sep 30, 2024 | -54.25 Mn |
| Jun 30, 2024 | -39.70 Mn |
| Mar 31, 2024 | -26.91 Mn |
| Dec 31, 2023 | -52.55 Mn |
| Sep 30, 2023 | -47.63 Mn |
| Jun 30, 2023 | -43.12 Mn |
| Mar 31, 2023 | -39.68 Mn |
| Dec 31, 2022 | -32.43 Mn |
| Sep 30, 2022 | -28.59 Mn |
| Jun 30, 2022 | -27.28 Mn |
| Mar 31, 2022 | -27.98 Mn |
| Dec 31, 2021 | -18.79 Mn |
| Sep 30, 2021 | -15.09 Mn |
| Jun 30, 2021 | -18.07 Mn |